Redspin Releases IT Security Advisory for Healthcare CEOs

Published on:

CARPINTERIA, Calif., Sept. 2, 2014--Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.

"Today's healthcare CEOs are presiding over the most dynamic period in the history of the industry," said Daniel W. Berger, Redspin's President and CEO. "The goal of our advisory is to help CEO's and their Boards of Directors understand why they need to elevate IT security to the level of corporate risk management."

Over the past 3 years, Redspin has led HIPAA IT security risk assessments at over 125 hospitals, hundreds of ambulatory clinics, and many business associates. "We've found that healthcare CEO's are both surprised and grateful when we report our security risk findings – this tells us that there is an information gap in the organization," continues Berger. "Our report gives CEO's practical recommendations on how to get more proactively involved in IT security."

The report, "What Healthcare CEO's Need to Know About IT Security Risk: Why Saving Costs Can Be Costly" is available for free download at: http://www.redspin.com/what-healthcare-ceos-need-to-know

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.